Headline
The latest stories from AHA Today.
In his state of the union address last night, President Trump said reducing prescription drug prices is “one of my greatest priorities.”
Centers for Disease Control and Prevention Director Brenda Fitzgerald, M.D., an obstetrician-gynecologist who previously served as Georgia’s public health commissioner and president-elect of the Association of State and Territorial Health Officials, resigned today.
The Food and Drug Administration yesterday released a blueprint for educating health care providers that treat or monitor patients with pain.
The act updated federal requirements for drug compounding facilities after a 2012 fungal meningitis outbreak that was associated with a contaminated compounded steroid medication distributed to patients and providers in 23 states.
The Centers for Medicare & Medicaid Services will host a Feb. 13 call on its new settlement option for health care providers with a low volume of appeals pending at the Office of Medicare Hearings and Appeals and Medicare Appeals Council.
The AHA’s Health Research & Educational Trust affiliate is leading a study to identify the key factors that facilitate performance improvement in safety-net hospitals.
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. will create an independent company “free from profit-making incentives and constraints” to address health care for their U.S. employees, the organizations announced today.
Baxter Healthcare Corp. Friday updated U.S. hospital customers on its efforts to address a critical shortage of intravenous solutions since Hurricane Maria impacted its manufacturing facilities in Puerto Rico.
The agency today extended for another six months its moratoria on enrollment of new Medicare home health agencies and and on new Part B non-emergency ground ambulance suppliers in certain states.
Critical access hospitals that did not achieve meaningful use in the Medicare Electronic Health Record Incentive Program for the 2016 reporting period or receive a hardship exception will see their Medicare payments reduced to 100% of their reasonable costs in fiscal year 2018.